Gain Therapeutics (GANX) vs Verrica Pharmaceuticals (VRCA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Verrica Pharmaceuticals (VRCA) has outperformed Gain Therapeutics (GANX) over the past year, losing 5.4% versus a loss of 17.3%. Over five years, GANX leads with a -75.9% price change compared with -96.9% for VRCA. Verrica Pharmaceuticals is the larger company by market cap ($71.8 million vs $70.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GANX | VRCA |
|---|---|---|
| Share price | $1.62 | $4.18 |
| Market cap | $70.48M | $71.81M |
| 1-day change | -3.29% | +0.97% |
| YTD return | -48.14% | -49.70% |
| 1-year return | -17.33% | -5.43% |
| 5-year return | -75.94% | -96.87% |
| EPS (TTM) | $-0.50 | $-1.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.34 | $9.82 |
| 52-week low | $1.53 | $3.28 |
| Distance from 52-week high | -62.79% | -57.44% |
| Average volume | 497.54K | 62.53K |
| Shares outstanding | 43.64M | 17.18M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VRCA has outperformed GANX by 11.9 percentage points over the past year.
GANX vs VRCA FAQ
Which is bigger, Gain Therapeutics or Verrica Pharmaceuticals?
Verrica Pharmaceuticals (VRCA) is larger, with a market capitalization of $71.81M compared with $70.48M for Gain Therapeutics (GANX).
Which stock has performed better over the past year, GANX or VRCA?
VRCA returned -5.43% over the past 12 months, compared with -17.33% for GANX (price return, excluding dividends). Past performance does not predict future results.
Are Gain Therapeutics and Verrica Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.